Record · corpus.blog/posts/01a0f576-b8a4-72cc-b1d6-42a587465b9c
IMMUNORARE5: A national platform of 5 academic phase II trials coordinated by Lyon University Hospital to assess the safety and the efficacy of the immunotherapy with domvanalimab + zimberelimab combination in patients with advanced rare cancers—The Peritoneal Mesotheliomas Cohort.
$whoami : echo “tp53(ashish), ml + {medicine, biology} tinkerer” - tp53(ashish)’s home on the interwebs · published 30 September 2026
A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.
0blogs citing
- First cited
- —
- Most recent
- —
- Rank this month
- not ranked
- External links
- 0
- Words captured
- 342
Cited by
No blog we hold has cited this post yet.
Similar posts
Dene’s story: helping the future of cancer treatment
guysandstthomas.nhs.uk
1 Oct 2026
Innovation and research: Making a difference in cancer treatment and care
guysandstthomas.nhs.uk
1 Oct 2026
Links from this post
This post doesn't link to any pages we've captured.